Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial

Abstract Objectives Evidence suggests that ketamine’s influence on brain-derived neurotrophic factor (BDNF) might be involved in its mechanism of rapid antidepressant action. We aimed to evaluate the differential impact of ketamine and esketamine on serum BDNF levels and its association with respo...

Повний опис

Бібліографічні деталі

Автори:	Ana Teresa Caliman-Fontes, Gustavo C. Leal, Fernanda S. Correia-Melo, Camilla S. Paixao, Michelle S. Carvalho, Ana Paula Jesus-Nunes, Flavia Vieira, Guilherme Magnavita, Igor D. Bandeira, Rodrigo P. Mello, Graziele Beanes, Samantha S. Silva, Mariana Echegaray, Lucas P. Carvalho, Paulo Machado, Aline S. Sampaio, Taiane de A. Cardoso, Flávio Kapczinski, Acioly L. T. Lacerda, Lucas C. Quarantini
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Associação de Psiquiatria do Rio Grande do Sul 2023-02-01
Серія:	Trends in Psychiatry and Psychotherapy
Предмети:	BDNF biochemical markers major depressive disorder NMDA antagonists neurotrophins
Онлайн доступ:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-60892023000100405&lng=en&tlng=en
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!